Fundraising Fox

Avoro Ventures

Venture capitalActively deploying

New York

Fox Verdict
Sign up to see your fit

Fund manager profile

Avoro Ventures is a venture fund manager based in New York. SEC filings show 2 venture funds on record, most recently Avoro Ventures Fund II L.P. filed July 2026.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
New York, US
Founded
2020
Tracked investments
2

What they invest in

from 2 of 2 portfolio companies

Biotech ×2Healthtech ×2Deep Tech ×1Medical Devices ×1

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path

By year:2025 · 12021 · 12 dated

Aadi Bioscienceaadibio.cominNASDAQ: WHWKMar 2025SEC filingmedium confidence

Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.

BiotechHealthtechMorristown, US

Scott Giacobello(Executive Officer)Bryan Ball(Executive Officer)Dave Lennon(Executive Officer, Director)David Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)

Board seatBehzad Aghazadeh· per SEC Form D · $100M raise · filed Mar 2025

Co-investors3B Future Health FundAlly Bridge GroupDecheng CapitalVivo CapitalOrbiMed

Scribe Therapeuticsscribetx.comin𝕏NASDAQ: SCTXMar 2021SEC filingmedium confidence

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Benjamin Oakes(Founder & CEO)Jennifer A. Doudna, PhD(Co-founder, Scientific Advisor)Benjamin L. Oakes, PhD(Co-founder, President and CEO)David F. Savage, PhD(Co-founder, Scientific Advisor)Brett Staahl, PhD(Co-founder, VP of External Innovation)

BoardVijay Pande(Director)in

Board seatBehzad Aghazadeh· per SEC Form D · $100M raise · filed Apr 2021

Co-investorsAndreessen HorowitzOrbiMedAvoro Capital AdvisorsMenlo VenturesRA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 2

IPOs and acquisitions across the tracked portfolio

Aadi BioscienceNASDAQ: WHWKScribe TherapeuticsNASDAQ: SCTX

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is Avoro Ventures located?
Avoro Ventures is headquartered in New York, US.

Featured in lists